(Q34818891)

English

Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised pla

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised pla (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

psoriatic arthritis

1 reference

based on heuristic

Dafna D. Gladman

2

object named as

D Gladman

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Désirée van der Heijde

3

object named as

D van der Heijde

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

A Kavanaugh

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

O Purcaru

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

P Mease

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

18 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

44-51

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity in patients with psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Work productivity in rheumatoid arthritis: relationship with clinical and radiological features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Psoriatic arthritis: a critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Work disability in psoriatic arthritis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Review of the costs of illness of ankylosing spondylitis and methodologic notes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Analysis of cost data in randomized trials: an application of the non-parametric bootstrap

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

8 July 2018

High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205198

21 January 2018

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205198

21 January 2018

Work disability and health-related quality of life in males and females with psoriatic arthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205198

21 January 2018

Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205198

21 January 2018

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205198

21 January 2018

Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

26 October 2018

Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283690

26 October 2018

The economic burden of rheumatoid arthritis: beyond health care costs

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205198

21 January 2018

A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/24942382

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24942382

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24942382

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24942382

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification criteria for psoriatic arthritis: development of new criteria from a large international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24942382

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ANNRHEUMDIS-2014-205198

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34818891&oldid=1639257750"